You are not currently logged in.
Access JSTOR through your library or other institution:
Coadministration of Oral Levofloxacin With Agents That Impair Absorption: Impact on Antibiotic Resistance
Keira A. Cohen , BS, Ebbing Lautenbach , MD, MPD, MSCE, Mark G. Weiner , MD, Marie Synnestvedt , MSED and Leanne B. Gasink , MD, MSCE
Infection Control and Hospital Epidemiology
Vol. 29, No. 10 (October 2008), pp. 975-977
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/590666
Page Count: 3
You can always find the topics here!Topics: Fluoroquinolones, Dosage, Hospital admissions, Antibiotics, Medication administration, Oral administration, Hospital administration, P values, Predisposing factors, Infections
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Coadministration of oral divalent or trivalent cation‐containing compounds with oral fluoroquinolones may impair fluoroquinolone absorption. Among 3,134 patients who received a course of oral levofloxacin, coadministration was significantly associated with subsequent identification of a levofloxacin‐resistant isolate. Strategies to curb the emergence of fluoroquinolone resistance should include avoiding the coadministration of divalent or trivalent cation‐containing compounds and fluoroquinolone.
© 2008 by The Society for Healthcare Epidemiology of America. All rights reserved.